Our understanding of nonalcoholic fatty liver disease pathophysiology continues to advance
rapidly. Accordingly, the field has moved from describing the clinical phenotype through the …

Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized public health
problem, affecting up to a quarter of the world's adult population. The burden of NAFLD is …

Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …

Background & Aims Apoptosis signal-regulating kinase 1 (ASK1) plays a key role in
hepatocyte injury, inflammation, and fibrosis in non-alcoholic steatohepatitis (NASH). We …

NAFLD has become a major public health problem for more than 2 decades with a growing
prevalence in parallel with the epidemic of obesity and type 2 diabetes (T2D). The disease …

Abstract Background and Aim Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic
steatohepatitis (NASH) account for a large and growing proportion of liver disease burden …

Background Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver
disease worldwide. This study aimed to estimate the prevalence, incidence, and outcome of …

Background: The increasing burden of non-alcoholic fatty liver disease (NAFLD) worldwide
imposes an emerging public health issue. We perform the current study to estimate the …

Metabolic associated fatty liver disease (MAFLD), previously termed non-alcoholic fatty liver
disease, is the leading global cause of liver disease and is fast becoming the most common …

Alterations in body composition, in particular sarcopenia and sarcopenic obesity, are
complications of liver cirrhosis associated with adverse outcomes. This systematic review …